Form D · Biotechnology

Oncoscope Inc

Durham, NC · CIK 0001420865

Offering snapshot reported Oct 12, 2012 · SEC filing

Reported sold
$450K
Offering amount: $1M
Investors reported
23
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 2, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 12, 2012Initial$449,964No comparison23SEC filing
Aug 25, 2011Amendment$2,000,000$1,109,263vs Jul 21, 201140SEC filing
Jul 21, 2011Amendment$890,737$265,835vs Apr 21, 201134SEC filing
Apr 21, 2011Initial$624,902No comparison25SEC filing
May 18, 2010Initial$1,198,184No comparison20SEC filing
Mar 11, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Dec 7, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-185463

Source: Form D, filed Oct 12, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Autrey Executive
Lister Delgado Director
James Dougherty Director
Perry A Genova Director, Executive
Matthew Megaro Director
Daniel Pelak Director
Paul Priu Director
Adam Wax Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
318 Blackwell Street, Suite 240
Durham, NC, 27701